Company Profile
Puma Biotechnology Inc Stock Price, News & Analysis
- Ticker:
- PBYI
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
8.12 USD (+1.63%)
Close
Last updated: August 6, 2026
355M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, PBYI closed up 1.63% at $8.12. No new same-company headline was identified in the current news window.
Company overview
Business overview
Puma Biotechnology is an oncology company focused on breast-cancer therapy and targeted cancer medicines. Its business has long centered on a concentrated commercial oncology franchise.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Puma sits in specialty oncology biotechnology.
Business Model Characteristics
The company depends on product revenue, market access, and the durability of its commercial cancer portfolio.
Position Within the Biotechnology Landscape
Puma is a commercial oncology name with limited breadth but meaningful sensitivity to product execution.
Future catalysts
Puma Biotechnology’s catalysts are NERLYNX execution and any label / oncology update that extends the franchise. Investors will care about whether the commercial base can keep hanging on.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Puma Biotechnology Inc (PBYI)?
Puma Biotechnology Inc (PBYI) most recently closed at 8.12 USD, a +1.63% move versus the previous session.
What is the market cap of Puma Biotechnology Inc (PBYI)?
Puma Biotechnology Inc currently has a market capitalization of 355M USD on BioPharmSignal.
What does Puma Biotechnology Inc do?
Puma Biotechnology is an oncology company focused on breast-cancer therapy and targeted cancer medicines. Its business has long centered on a concentrated commercial oncology franchise.
On which exchange is PBYI stock listed?
Puma Biotechnology Inc (PBYI) is associated with NASDAQ, United States, Biopharma.
What is Puma?
Puma Biotechnology’s catalysts are NERLYNX execution and any label / oncology update that extends the franchise.
Which conditions is Puma Biotechnology Inc targeting with Puma?
Puma Biotechnology Inc is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Puma Biotechnology Inc describe recent progress with Puma?
Puma Biotechnology’s catalysts are NERLYNX execution and any label / oncology update that extends the franchise.
What is Biotechnology?
Puma Biotechnology is an oncology company focused on breast-cancer therapy and targeted cancer medicines.